PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
D000970:Antineoplastic Agents; D004358:Drug Therapy; D006689:Hodgkin Disease; D006918:Hydroxyurea; D007970:Leukopenia; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009101:Multiple Myeloma; D009369:Neoplasms; D012509:Sarcoma; D013921:Thrombocytopenia; D014116:Toxicology; D014508:Urea
D000970:Antineoplastic Agents; D014508:Urea; D006918:Hydroxyurea
ANTINEOPLASTIC AGENTS; DRUG THERAPY; HODGKIN'S DISEASE; LEUKOPENIA; MULTIPLE MYELOMA; SARCOMA, RETICULUM CELL; THROMBOPENIA; TOXICOLOGIC REPORT; UREA